APTV vs COLL · P/E 41, rev $19.71B vs P/E 17, rev $181.9M
Aptiv PLC (APTV) versus Collegium Pharmaceutical Inc (COLL) — a side-by-side from cached financials, not a winner call.
Aptiv PLC (APTV) is a auto parts company listed on US.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported APTV revenue for 2024-12-31 was $19.71B. Net income was $275.0M. Revenue was down 1.7% from 2023-12-31 to 2024-12-31. APTV currently screens at market cap $14.52B and trailing P/E 40.8.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
APTV currently screens at market cap $14.52B and trailing P/E 40.8. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
Not investment advice. Open the APTV and COLL stock pages for the full models.
Not investment advice.